Table 2 Clinical and biological parameters at hospital admission in the 383 hospitalized patients
From: Development of a bedside score to predict dengue severity
Clinical parameters | Number (%) |
Symptom | |
Fever | 347 (90.6%) |
Muscle soreness/myalgia | 249 (65.0%) |
Arthralgia | 174 (45.4%) |
Headache | 261 (68.1%) |
Retro-orbital pain | 98 (25.6%) |
Diarrhea | 129 (33.7%) |
Nausea/vomiting | 209 (54.6%) |
Skin rash | 130 (33.9%) |
Conjunctival hyperemia | 41 (10.7%) |
Edema | 18 (4.7%) |
Gingivorrhagia | 58 (15.1%) |
Purpura | 78 (20.4%) |
Epistaxis | 58 (15.1%) |
Hematuria/blood in stools | 19 (5.0%) |
Shock syndrome | 26 (6.8%) |
Major bleeding | 47 (12.3%) |
Alert signs | |
Abdominal pain | 147 (38.4%) |
Persistent vomiting | 42 (11.0%) |
Clinical liquid accumulation | 28 (7.3%) |
Mucosal bleeding | 170 (44.4%) |
Lethargy/anxiety | 72 (18.8%) |
Hepatomegaly | 17 (4.4%) |
Increase in hematocrit + drop in platelets count | 68 (17.8%) |
Biological parameters | Median [min; max] (% of available results) |
Platelets (109/L) | 48 [3; 360] (93.7) |
Hemoglobin (g/dL) | 14 [6; 22] (94.5) |
Hematocrit (%) | 41 [16; 61] (94) |
Neutrophils (/mm3) | 1895 [320; 19020] (92) |
Lymphocytes (/mm3) | 1535 [140; 8940] (90.8) |
Albuminaemia (g/L) | 36 [19; 46] (13.8) |
Protidaemia (g/L) | 58 [24; 91] (10.4) |
Urea (mmol/L) | 4 [0; 41] (76) |
Creatinin (μmol/L) | 71 [18; 927] (78.3) |
AST (IU/L) | 184 [17; 10336] (85) |
ALT (IU/L) | 116 [9; 8040] (85) |
CPK | 305 [3–74063] (28) |
Lipase (IU/L) | 53 [9; 2707] (33.4) |
CRP (mg/L) | 14 [0; 327] (56.6) |